Piramal Healthcare Chairman Ajay Piramal On Meeting The World's Need For High Quality Delivered At Low Cost: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Ajay Piramal, chairman of the $550 million Piramal Healthcare and Piramal Lifesciences, has brought up his company in the last 20 years, working ceaselessly on signing marketing arrangements with multinational companies for the Indian market, strategic buyouts both in India and abroad, carving out contract manufacturing and then establishing a discovery research entity. Known as the takeover tycoon in Indian corporate circles, Piramal has closed important deals with top-notch global companies like Pfizer. From inheriting a fledgling textiles business in the 1980s to putting together a strong pharmaceutical business from scratch, Ajay Piramal sat down with PharmAsia News' India Bureau to share his vision for the company.